MONTREAL, Aug. 25, 2016 /CNW Telbec/ - Thorasys, an innovative Montreal medical company, will be able to accelerate its development thanks to significant financial support from Anges Québec.
"We had to find credible financial partners able to support us at this new stage of our development. Anges Québec's support for our board of directors and our financing efforts will enable us to get our solutions to market faster and meet the growing need for our technology," said Thorasys president and CEO Thomas Schuessler.
The new funds will allow the company to better organize its efforts to commercialize the tremoFlo™ C-100 Airwave Oscillometry System (AOS)™, a portable device designed to facilitate the diagnosis of lung diseases in order to improve treatment.
Thorasys has developed a technology for assessing lung function without patient effort, whereas current techniques require substantial effort and coordination by patients and healthcare professionals. Moreover, the technology developed by the Montreal company provides a detailed assessment of changes in and around the lungs. This makes it possible to detect lung diseases even faster. These are the two major advantages that set Thorasys apart from the competition.
"The expertise developed by Thorasys over the years and the quality of the tremoFlo™ C-100 Airwave Oscillometry System (AOS) were key factors in our decision to support Thomas and his team," said Marcel Larochelle and Xavier Harland, two angel investors. "We're happy our contribution will help Thorasys pursue its successful growth."
Thorasys Thoracic Medical Systems Inc. is a Montreal-based company that leverages cutting edge research and technology to develop products for the diagnosis and monitoring of lung diseases such as asthma and COPD using the Forced Oscillation Technique (FOT).
About Anges Québec
Anges Québec is a network of 180 private investors that finds, finances, and coaches innovative Quebec companies with high growth potential. In this capacity, Anges Québec works with a number of key Quebec organizations interested in the development and growth of technological innovations. So far, Anges Québec members have invested and reinvested in more than 100 promising business in the seed and startup phases.
About the Anges Québec Capital fund
Anges Québec Capital is an investment fund set up to invest alongside the members of Anges Québec. Sponsored by the Government of Quebec, Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ, and Investissement Québec, the fund supports the angels who invest in innovative Quebec businesses in the seed or startup phase. The joint efforts of angels and fund sponsors have made $85 million available to entrepreneurs.
For more information about the Anges Québec network, go to www.angesquebec.com. Join our LinkedIn.com group for news and information about Anges Québec activities. An English version is available online at www.angesquebec.com/en/nouvelles.
Une version française est disponible en ligne : www.angesquebec.com/fr/nouvelles.
SOURCE Anges Québec
For further information: Marco Parent, 514 349-7778, email@example.com